Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial
Background The relative feasibility and acceptability of daily versus non-daily dosing of oral
HIV pre-exposure prophylaxis (PrEP) among women are unknown. We aimed to investigate …
HIV pre-exposure prophylaxis (PrEP) among women are unknown. We aimed to investigate …
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men
DK Smith, RM Grant, PJ Weidle, A Lansky, J Mermin… - 2011 - stacks.cdc.gov
An estimated 56,000 human immunodeficiency virus (HIV) infections occur each year in the
United States. Men who have sex with men (MSM) account for 53% of the estimated incident …
United States. Men who have sex with men (MSM) account for 53% of the estimated incident …
Cost-effectiveness of long-acting injectable HIV preexposure prophylaxis in the United States: a cost-effectiveness analysis
AM Neilan, RJ Landovitz, MH Le… - Annals of internal …, 2022 - acpjournals.org
Background: The HIV Prevention Trials Network (HPTN) 083 trial demonstrated the
superiority of long-acting injectable cabotegravir (CAB-LA) compared with oral emtricitabine …
superiority of long-acting injectable cabotegravir (CAB-LA) compared with oral emtricitabine …
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants
JD Fuchs, ME Sobieszczyk, T Madenwald… - JAIDS Journal of …, 2013 - journals.lww.com
In November 2010, the iPrEx study reported that preexposure prophylaxis (PrEP) with daily
tenofovir disoproxil fumarate/emtricitabine reduced HIV infections by 44% among men who …
tenofovir disoproxil fumarate/emtricitabine reduced HIV infections by 44% among men who …
Cost-effectiveness of alternative strategies for provision of HIV preexposure prophylaxis for people who inject drugs
R Fu, DK Owens, ML Brandeau - Aids, 2018 - journals.lww.com
Background: Oral HIV preexposure prophylaxis (PrEP) has been recommended as a means
of HIV prevention among people who inject drugs (PWIDs) but, at current prices, is unlikely …
of HIV prevention among people who inject drugs (PWIDs) but, at current prices, is unlikely …
[HTML][HTML] Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics
SS Alistar, DK Owens, ML Brandeau - PLoS One, 2014 - journals.plos.org
Background Pre-exposure prophylaxis with oral antiretroviral treatment (oral PrEP) for HIV-
uninfected injection drug users (IDUs) is potentially useful in controlling HIV epidemics with …
uninfected injection drug users (IDUs) is potentially useful in controlling HIV epidemics with …
[HTML][HTML] Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting
Background The HIV epidemic in the United States (US) disproportionately affects gay,
bisexual, and other men who have sex with men (MSM). Pre-exposure prophylaxis (PrEP) …
bisexual, and other men who have sex with men (MSM). Pre-exposure prophylaxis (PrEP) …
[HTML][HTML] Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States
ES Rosenberg, JL Marcus - Annals of epidemiology, 2018 - ncbi.nlm.nih.gov
Once-daily emtricitabine/tenofovir for HIV preexposure prophylaxis (PrEP) has emerged as a
primary tool for HIV prevention. PrEP has been shown to be highly effective in clinical trials1 …
primary tool for HIV prevention. PrEP has been shown to be highly effective in clinical trials1 …
[HTML][HTML] Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling …
H Choi, J Suh, W Lee, JH Kim, JH Kim, H Seong… - Scientific reports, 2020 - nature.com
Abstract In February 2018, the Ministry of Food and Drug Safety in Korea approved tenofovir
disoproxil fumarate and emtricitabine (TDF/FTC) co-formulate for use in pre-exposure …
disoproxil fumarate and emtricitabine (TDF/FTC) co-formulate for use in pre-exposure …
Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV
acquisition, yet significant barriers exist to its prescription and use. Incorporating …
acquisition, yet significant barriers exist to its prescription and use. Incorporating …